The effectiveness and cost-effectiveness of treatment by homeopaths in addition to usual care for depressed patients

Not Applicable

Completed

• Conditions: Self-reported depression; Mental and Behavioural Disorders; Depressive episode, unspecified

• Registration Number: ISRCTN02484593
• Lead Sponsor: niversity of Sheffield (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01-07
• Last Update Posted: 21 August 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 485

Inclusion Criteria

1. Patients with self-reported depression indicated by a minimum PHQ-9 score of 10 with a minimum of two symptoms scoring 2 points including at least either question 1 (little interest or pleasure in doing things) or question 2 (feeling down, depressed, or hopeless)
2. Aged 18 to 85 years
3. Are able to speak and read English
4. Have given informed consent

Exclusion Criteria

1. Patients with PHQ-9 scores below 10 or less than 2 symptoms scoring 2 points or neither question 1 nor question 2 scoring 2 points
2. Patients who report current or past psychiatric diagnosis (other than depression) including bipolar disorder, Alzheimer's disease, organic brain damage, schizophrenia, schizoaffective disorders, other psychotic disorders, or antisocial personality disorder
3. Patients who have received homeopathic treatment over the past 3 months
4. Patients who are currently involved in another health research project
5. Patients who due to reduced intellectual capacity or illiteracy are unable to read or understand study questionnaires and accompanying information

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient Health Questionnaire (PHQ-9) at 6 months

Secondary Outcome Measures

Name	Time	Method
1. Patient Health Questionnaire (PHQ-9) at 12 months, and the following at 6 and 12 months<br>2. Generalized Anxiety Disorder 7-item (GAD-7) scale at 6 and 12 months<br>3. EuroQol (EQ-5D) at 6 and 12 months<br>4. Measure Yourself Medical Outcome Profile (MYMOP2) at 6 and 12 months<br>5. Body Mass Index (BMI) at 6 and 12 months<br>6. Life satisfaction score at 6 and 12 months